Ralliant Corporation $RAL Shares Acquired by Principal Financial Group Inc.

Principal Financial Group Inc. boosted its position in shares of Ralliant Corporation (NYSE:RAL) by 2.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 546,560 shares of the company’s stock after purchasing an additional 10,592 shares during the period. Principal Financial Group Inc.’s holdings in Ralliant were worth $22,731,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Dodge & Cox lifted its holdings in Ralliant by 13.3% in the 4th quarter. Dodge & Cox now owns 12,214,679 shares of the company’s stock worth $621,849,000 after buying an additional 1,434,376 shares in the last quarter. Viking Global Investors LP acquired a new stake in shares of Ralliant during the second quarter valued at about $257,200,000. Millennium Management LLC increased its position in shares of Ralliant by 172.4% during the fourth quarter. Millennium Management LLC now owns 4,973,001 shares of the company’s stock worth $253,175,000 after acquiring an additional 3,147,660 shares during the last quarter. State Street Corp purchased a new stake in shares of Ralliant during the second quarter worth about $213,096,000. Finally, Invesco Ltd. lifted its stake in shares of Ralliant by 4.9% in the fourth quarter. Invesco Ltd. now owns 4,059,588 shares of the company’s stock worth $206,674,000 after acquiring an additional 187,898 shares in the last quarter.

Ralliant Trading Up 2.0%

Ralliant stock opened at $71.15 on Wednesday. The firm’s 50-day moving average is $65.86 and its 200-day moving average is $53.42. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.05 and a current ratio of 1.61. Ralliant Corporation has a 1 year low of $37.27 and a 1 year high of $75.41. The company has a market cap of $7.96 billion and a P/E ratio of -6.50.

Ralliant (NYSE:RAL) last posted its quarterly earnings results on Tuesday, May 12th. The company reported $0.57 EPS for the quarter, beating the consensus estimate of $0.49 by $0.08. Ralliant had a negative net margin of 58.55% and a positive return on equity of 12.49%. The business had revenue of $534.60 million during the quarter. The firm’s revenue was up 11.0% on a year-over-year basis. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. On average, equities analysts expect that Ralliant Corporation will post 2.64 earnings per share for the current year.

Ralliant Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 8th were paid a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date was Monday, June 8th. Ralliant’s payout ratio is presently -1.83%.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Evercore assumed coverage on Ralliant in a report on Tuesday, June 9th. They issued an “outperform” rating and a $80.00 price target for the company. Truist Financial reaffirmed a “buy” rating and issued a $68.00 target price (up from $53.00) on shares of Ralliant in a research report on Wednesday, May 13th. BMO Capital Markets assumed coverage on shares of Ralliant in a research report on Monday. They set a “market perform” rating and a $78.00 price target for the company. TD Cowen raised their price target on shares of Ralliant from $55.00 to $70.00 and gave the stock a “buy” rating in a research report on Wednesday, May 20th. Finally, Barclays upped their price target on shares of Ralliant from $52.00 to $67.00 and gave the company an “overweight” rating in a report on Wednesday, May 13th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Ralliant currently has a consensus rating of “Moderate Buy” and an average target price of $73.00.

Ralliant Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.